Medical News

RSS

More women die of breast cancer in areas where mammography centers are few

More women die of breast cancer in areas where mammography centers are few and far between, according to research by a Medical College of Georgia radiology resident.

12 Jan 2010

U.S. changes HIV policy to allow foreigners with virus to enter

Los Angeles Times: "Last Monday, for the first time in 22 years, foreigners with HIV were legally allowed to enter the United States without their infection status being considered. Before that, even short-term visitors had to receive special permission — or lie on their visa application — to come here.

12 Jan 2010

Cognitively stimulating activities are beneficial, but mental exercises help some more than others

If you don't have a college degree, you're at greater risk of developing memory problems or even Alzheimer's. Education plays a key role in lifelong memory performance and risk for dementia, and it's well documented that those with a college degree possess a cognitive advantage over their less educated counterparts in middle and old age.

12 Jan 2010

Public awareness campaign needed to curb health threats posed by hepatitis B and hepatitis C

Stepped-up vaccination requirements, a boost in resources for prevention and treatment, and a public awareness campaign similar to the effort that dispelled the stigma of HIV/AIDS are needed to curb the health threats posed by hepatitis B and hepatitis C, says a new report from the Institute of Medicine.

12 Jan 2010

Proteinuria, a long accepted indicator of heart disease risk, has less impact on African-Americans compared to whites

The cardiovascular risk that is associated with proteinuria, or high levels of protein in the urine, a common test used by doctors as an indicator of increased risk for progressive kidney disease, heart attack and stroke, has race-dependent effects, according to a new study by researchers at Wake Forest University School of Medicine.

12 Jan 2010

YM BioSciences announces results of cancer antibody-radionuclide conjugate development collaboration

YM BioSciences Inc. today announced results of a collaboration with researchers at the University of Toronto for the development of highly potent antibody-radionuclide conjugates for use in the treatment of cancer. The approach has successfully concluded its first series of proof-of-principle experiments establishing promise for future development and application.

12 Jan 2010

GSK exercises option to obtain exclusive license to develop and commercialize Traficet-EN

GlaxoSmithKline (GSK) and ChemoCentryx, Inc. today announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialization of Traficet-EN(TM) (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn's disease.

12 Jan 2010

Flawed medical research could lead to children receiving treatment that either does not work or is harmful

Lisa Hartling, co-director for the University of Alberta's Alberta Research Centre for Health Evidence, looked at 163 North American clinical trials involving children by using a new tool that rates the risk of bias, meaning the benefits and safety of the treatments may have been exaggerated.

12 Jan 2010

Researchers identify genetic variant linked with the risk of prostate cancer

Researchers at Wake Forest University Baptist Medical Center and colleagues have identified the first genetic variant associated with aggressive prostate cancer, proving the concept that genetic information may one day be used in combination with other factors to guide treatment decisions.

12 Jan 2010

KV Pharmaceutical, Hologic amend Gestiva asset purchase agreement

KV Pharmaceutical Company ( KVa/KVb) today announced it has entered into an amendment to the existing asset purchase agreement with Hologic, Inc. to secure the full U.S. and worldwide rights to Gestiva(TM), subject to the terms and conditions set forth in the amendment. Upon approval by the U.S. Food and Drug Administration (the "FDA"), Gestiva(TM) will be the first and only FDA-approved treatment for the prevention of preterm birth in women who are pregnant with a single baby and have spontaneously delivered a single baby preterm in the past.

From Hologic, Inc. 12 Jan 2010

University of Haifa receives grant to investigate role of protein expression in memory formation

Prof. Kobi Rosenblum, Head of the Department of Neurobiology and Ethology at the University of Haifa, has been awarded a -1.6 million grant from DIP, a German-Israeli Project Cooperation, over a five-year period. This grant will fund Prof. Rosenblum's international research of the role of protein expression in memory formation and stability.

12 Jan 2010

Detroit paper explores pain of facing breast cancer without insurance

A woman with a $7,000 annual income and $67 in the bank was diagnosed with breast cancer, leading to a week of phone calls from her surgeon to state, federal and hospital officials before a charitable agreement was struck with a medical center, the Detroit Free Press reports.

12 Jan 2010

Jobs numbers in health sector defy recession, more growth expected

As most sectors of the economy shed jobs last month, health care companies continued to defy the pattern and hire more people in a trend that's spanned more than two years, Kaiser Health News reports. The main reason is that people are reluctant to skip health care services, even when times are tight, economists say. That factor, combined with an aging population allowed health care business to grow, albeit more slowly than normal, even as the broader economy flagged (Weaver, 1/8).

12 Jan 2010

Insecticide-treated net reduces malaria infection in pregnant women, but simple measures needed to increase effectiveness

A Tanzanian program to supply insecticide treated nets to prevent malaria in pregnant women successfully delivers the intervention to only 30% of women, but simple changes could increase effectiveness, according to an article http://www.cmaj.ca/embargo/cmaj090268.pdf in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.

12 Jan 2010

Researchers study VA111913 drug as a possible treatment for dysmenorrhea

A leading clinical research center in Austin has joined an international research program to study an investigational drug designed as a possible treatment for painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women of childbearing age in the United States.

12 Jan 2010

Pfizer commences SBI-087 Phase 2 clinical trial for RA

Trubion Pharmaceuticals, Inc. today announced that its collaboration partner, Pfizer, has initiated a Phase 2 clinical trial of SBI-087 (PF-05230895) for the treatment of rheumatoid arthritis (RA). SBI-087 is a next-generation, humanized Small Modular ImmunoPharmaceutical (SMIP(TM)) protein therapeutic directed against the CD20 antigen. SBI-087 is also being evaluated in Phase 1 clinical trials for RA and systemic lupus erythematosus (SLE).

12 Jan 2010

AmerisourceBergen announces new programs for long term care and retail pharmacies

AmerisourceBergen, under its’ PRxO® Generics Solution, today announced a new program for long term care pharmacies and an expanded program for retail pharmacies. The new solutions are tailored to better meet customer needs as generic prescription demands continue to increase.

12 Jan 2010

American Lung Association supports CDC's NIVW to highlight the importance influenza vaccination

The American Lung Association supports the Centers for Disease Control and Prevention's (CDC) National Influenza Vaccination Week (NIVW), January 10-16, 2010, which highlights the importance of annual influenza vaccination after the holiday season into January and beyond.

12 Jan 2010

Official H1N1-related death count approaches 13,000 worldwide, WHO says

H1N1 (swine flu) has killed 12,799 people worldwide since the virus first emerged, the WHO said on Friday, United Press International reports (1/8). According to the WHO, more than half of the H1N1-related deaths worldwide occurred in the Americas, China Daily reports (1/9).

12 Jan 2010

Biocomposites' geneX ds, the resorbable bone graft material with negative surface charge launched

Biocomposites, the pioneers in synthetic bone graft materials have launched geneX ds, a dual syringe mixing and minimally invasive delivery system containing geneX, the unique resorbable bone graft material with a negative surface charge.

12 Jan 2010

Medical News

More women die of breast cancer in areas where mammography centers are few

U.S. changes HIV policy to allow foreigners with virus to enter

Cognitively stimulating activities are beneficial, but mental exercises help some more than others

Public awareness campaign needed to curb health threats posed by hepatitis B and hepatitis C

Proteinuria, a long accepted indicator of heart disease risk, has less impact on African-Americans compared to whites

YM BioSciences announces results of cancer antibody-radionuclide conjugate development collaboration

GSK exercises option to obtain exclusive license to develop and commercialize Traficet-EN

Flawed medical research could lead to children receiving treatment that either does not work or is harmful

Researchers identify genetic variant linked with the risk of prostate cancer

KV Pharmaceutical, Hologic amend Gestiva asset purchase agreement

University of Haifa receives grant to investigate role of protein expression in memory formation

Detroit paper explores pain of facing breast cancer without insurance

Jobs numbers in health sector defy recession, more growth expected

Insecticide-treated net reduces malaria infection in pregnant women, but simple measures needed to increase effectiveness

Researchers study VA111913 drug as a possible treatment for dysmenorrhea

Pfizer commences SBI-087 Phase 2 clinical trial for RA

AmerisourceBergen announces new programs for long term care and retail pharmacies

American Lung Association supports CDC's NIVW to highlight the importance influenza vaccination

Official H1N1-related death count approaches 13,000 worldwide, WHO says

Biocomposites' geneX ds, the resorbable bone graft material with negative surface charge launched

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News